Predictive Clinical Trials

1 recruiting

Predictive Trials at a Glance

8 actively recruiting trials for predictive are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Amiens, Angers, and Aurillac. Lead sponsors running predictive studies include Elisabethinen Hospital, Fudan University, and Centre Hospitalier Universitaire, Amiens.

Browse predictive trials by phase

Treatments under study

About Predictive Clinical Trials

Looking for clinical trials for Predictive? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Predictive trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Predictive clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

Predictive Cancer ModelPathologic Complete Response
Sixth Affiliated Hospital, Sun Yat-sen University106 enrolled1 locationNCT06364371
Recruiting
Not Applicable

Vulnerability and Risk of Neuropathic Pain in Cancer

CancerNeuropathic PainPredictive
University Hospital, Clermont-Ferrand625 enrolled19 locationsNCT06511674
Recruiting
Not Applicable

Development and Validation of Virtual Laparoscopic Hiatal Hernia Simulator

Predictive Validity of VLaHHS
University of Texas Southwestern Medical Center20 enrolled1 locationNCT06974383
Recruiting
Not Applicable

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

ImmunotherapyImmune Checkpoint InhibitorsImmune-related Adverse Event+1 more
Centre Hospitalier Universitaire, Amiens150 enrolled1 locationNCT05813418
Recruiting

Slew Rate As a Predictor for Optimal Lead Fixation

Defibrillators, ImplantableElectrodes, ImplantedPacemaker, Artificial+1 more
Paolo Pastori, MD516 enrolled1 locationNCT06842940
Recruiting
Phase 3

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

Pancreatic CancerCirculating Tumor CellPredictive Cancer Model
Elisabethinen Hospital100 enrolled1 locationNCT06391892
Recruiting

Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model

MetastasisPredictive Cancer Model
Fudan University166 enrolled2 locationsNCT06202404
Recruiting

Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype

Predictive Cancer Model
Military University Hospital, Prague200 enrolled1 locationNCT05929365